Global Eczema Therapeutics Market 2024-2028

Global Eczema Therapeutics Market 2024-2028


The eczema therapeutics market is forecasted to grow by USD 5.81 bn during 2023-2028, accelerating at a CAGR of 10.28% during the forecast period. The report on the eczema therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of atopic dermatitis, increasing product launches for treating eczema, and increase in demand for over-the-counter (OTC) eczema drugs among end-users.

Technavio's eczema therapeutics market is segmented as below:

By Application
  • Atopic dermatitis
  • Contact dermatitis
  • Other indication
By Distribution Channel
  • Hospital and clinics
  • Online pharmacies
  • Retail pharmacies
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising adoption of telemedicine platforms in eczema therapeutics as one of the prime reasons driving the eczema therapeutics market growth during the next few years. Also, growing adoption of biologic therapies for eczema treatment and increasing healthcare expenditure surging demand for eczema therapeutics will lead to sizable demand in the market.

The report on the eczema therapeutics market covers the following areas:
  • Eczema therapeutics market sizing
  • Eczema therapeutics market forecast
  • Eczema therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading eczema therapeutics market vendors that include AbbVie Inc., Alliance Pharma PLC, Amneal Pharmaceuticals Inc., AstraZeneca PLC, Bausch Health Companies Inc., Bayer AG, Bristol-Myers Squibb Company, Cadila Pharmaceuticals Ltd., Eli Lilly and Co., Incyte Corp., LEO Pharma AS, Lupin Ltd., Mayo Clinic, Merck and Co. Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the eczema therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global eczema therapeutics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global eczema therapeutics market 2018 - 2022 ($ billion)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 Distribution channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Atopic dermatitis - Market size and forecast 2023-2028
Exhibit 34: Chart on Atopic dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Atopic dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Atopic dermatitis - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Atopic dermatitis - Year-over-year growth 2023-2028 (%)
6.4 Contact dermatitis - Market size and forecast 2023-2028
Exhibit 38: Chart on Contact dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Contact dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Contact dermatitis - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Contact dermatitis - Year-over-year growth 2023-2028 (%)
6.5 Other indication - Market size and forecast 2023-2028
Exhibit 42: Chart on Other indication - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Other indication - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Other indication - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Other indication - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Exhibit 46: Market opportunity by Application ($ billion)
Exhibit 47: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 50: Chart on Comparison by Distribution Channel
Exhibit 51: Data Table on Comparison by Distribution Channel
7.3 Hospital and clinics - Market size and forecast 2023-2028
Exhibit 52: Chart on Hospital and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Hospital and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Hospital and clinics - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Hospital and clinics - Year-over-year growth 2023-2028 (%)
7.4 Online pharmacies - Market size and forecast 2023-2028
Exhibit 56: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 64: Market opportunity by Distribution Channel ($ billion)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
12.4 Alliance Pharma PLC
Exhibit 119: Alliance Pharma PLC - Overview
Exhibit 120: Alliance Pharma PLC - Business segments
Exhibit 121: Alliance Pharma PLC - Key offerings
Exhibit 122: Alliance Pharma PLC - Segment focus
12.5 Amneal Pharmaceuticals Inc.
Exhibit 123: Amneal Pharmaceuticals Inc. - Overview
Exhibit 124: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 125: Amneal Pharmaceuticals Inc. - Key news
Exhibit 126: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 127: Amneal Pharmaceuticals Inc. - Segment focus
12.6 AstraZeneca PLC
Exhibit 128: AstraZeneca PLC - Overview
Exhibit 129: AstraZeneca PLC - Product / Service
Exhibit 130: AstraZeneca PLC - Key news
Exhibit 131: AstraZeneca PLC - Key offerings
12.7 Bausch Health Companies Inc.
Exhibit 132: Bausch Health Companies Inc. - Overview
Exhibit 133: Bausch Health Companies Inc. - Business segments
Exhibit 134: Bausch Health Companies Inc. - Key news
Exhibit 135: Bausch Health Companies Inc. - Key offerings
Exhibit 136: Bausch Health Companies Inc. - Segment focus
12.8 Bayer AG
Exhibit 137: Bayer AG - Overview
Exhibit 138: Bayer AG - Business segments
Exhibit 139: Bayer AG - Key news
Exhibit 140: Bayer AG - Key offerings
Exhibit 141: Bayer AG - Segment focus
12.9 Cadila Pharmaceuticals Ltd.
Exhibit 142: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 143: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibit 144: Cadila Pharmaceuticals Ltd. - Key news
Exhibit 145: Cadila Pharmaceuticals Ltd. - Key offerings
12.10 Eli Lilly and Co.
Exhibit 146: Eli Lilly and Co. - Overview
Exhibit 147: Eli Lilly and Co. - Product / Service
Exhibit 148: Eli Lilly and Co. - Key news
Exhibit 149: Eli Lilly and Co. - Key offerings
12.11 LEO Pharma AS
Exhibit 150: LEO Pharma AS - Overview
Exhibit 151: LEO Pharma AS - Business segments
Exhibit 152: LEO Pharma AS - Key offerings
Exhibit 153: LEO Pharma AS - Segment focus
12.12 Lupin Ltd.
Exhibit 154: Lupin Ltd. - Overview
Exhibit 155: Lupin Ltd. - Product / Service
Exhibit 156: Lupin Ltd. - Key news
Exhibit 157: Lupin Ltd. - Key offerings
12.13 Merck and Co. Inc.
Exhibit 158: Merck and Co. Inc. - Overview
Exhibit 159: Merck and Co. Inc. - Business segments
Exhibit 160: Merck and Co. Inc. - Key news
Exhibit 161: Merck and Co. Inc. - Key offerings
Exhibit 162: Merck and Co. Inc. - Segment focus
12.14 Novartis AG
Exhibit 163: Novartis AG - Overview
Exhibit 164: Novartis AG - Business segments
Exhibit 165: Novartis AG - Key news
Exhibit 166: Novartis AG - Key offerings
Exhibit 167: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 168: Pfizer Inc. - Overview
Exhibit 169: Pfizer Inc. - Product / Service
Exhibit 170: Pfizer Inc. - Key news
Exhibit 171: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 172: Sanofi SA - Overview
Exhibit 173: Sanofi SA - Business segments
Exhibit 174: Sanofi SA - Key news
Exhibit 175: Sanofi SA - Key offerings
Exhibit 176: Sanofi SA - Segment focus
12.17 Viatris Inc.
Exhibit 177: Viatris Inc. - Overview
Exhibit 178: Viatris Inc. - Business segments
Exhibit 179: Viatris Inc. - Key news
Exhibit 180: Viatris Inc. - Key offerings
Exhibit 181: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 182: Inclusions checklist
Exhibit 183: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 184: Currency conversion rates for US$
13.4 Research methodology
Exhibit 185: Research methodology
Exhibit 186: Validation techniques employed for market sizing
Exhibit 187: Information sources
13.5 List of abbreviations
Exhibit 188: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global eczema therapeutics market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Atopic dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Atopic dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Atopic dermatitis - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Atopic dermatitis - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Contact dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Contact dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Contact dermatitis - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Contact dermatitis - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Other indication - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Other indication - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Other indication - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Other indication - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Application ($ billion)
Exhibits47: Data Table on Market opportunity by Application ($ billion)
Exhibits48: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits49: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Distribution Channel
Exhibits51: Data Table on Comparison by Distribution Channel
Exhibits52: Chart on Hospital and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Hospital and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Hospital and clinics - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Hospital and clinics - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Distribution Channel ($ billion)
Exhibits65: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Alliance Pharma PLC - Overview
Exhibits120: Alliance Pharma PLC - Business segments
Exhibits121: Alliance Pharma PLC - Key offerings
Exhibits122: Alliance Pharma PLC - Segment focus
Exhibits123: Amneal Pharmaceuticals Inc. - Overview
Exhibits124: Amneal Pharmaceuticals Inc. - Business segments
Exhibits125: Amneal Pharmaceuticals Inc. - Key news
Exhibits126: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits127: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits128: AstraZeneca PLC - Overview
Exhibits129: AstraZeneca PLC - Product / Service
Exhibits130: AstraZeneca PLC - Key news
Exhibits131: AstraZeneca PLC - Key offerings
Exhibits132: Bausch Health Companies Inc. - Overview
Exhibits133: Bausch Health Companies Inc. - Business segments
Exhibits134: Bausch Health Companies Inc. - Key news
Exhibits135: Bausch Health Companies Inc. - Key offerings
Exhibits136: Bausch Health Companies Inc. - Segment focus
Exhibits137: Bayer AG - Overview
Exhibits138: Bayer AG - Business segments
Exhibits139: Bayer AG - Key news
Exhibits140: Bayer AG - Key offerings
Exhibits141: Bayer AG - Segment focus
Exhibits142: Cadila Pharmaceuticals Ltd. - Overview
Exhibits143: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits144: Cadila Pharmaceuticals Ltd. - Key news
Exhibits145: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits146: Eli Lilly and Co. - Overview
Exhibits147: Eli Lilly and Co. - Product / Service
Exhibits148: Eli Lilly and Co. - Key news
Exhibits149: Eli Lilly and Co. - Key offerings
Exhibits150: LEO Pharma AS - Overview
Exhibits151: LEO Pharma AS - Business segments
Exhibits152: LEO Pharma AS - Key offerings
Exhibits153: LEO Pharma AS - Segment focus
Exhibits154: Lupin Ltd. - Overview
Exhibits155: Lupin Ltd. - Product / Service
Exhibits156: Lupin Ltd. - Key news
Exhibits157: Lupin Ltd. - Key offerings
Exhibits158: Merck and Co. Inc. - Overview
Exhibits159: Merck and Co. Inc. - Business segments
Exhibits160: Merck and Co. Inc. - Key news
Exhibits161: Merck and Co. Inc. - Key offerings
Exhibits162: Merck and Co. Inc. - Segment focus
Exhibits163: Novartis AG - Overview
Exhibits164: Novartis AG - Business segments
Exhibits165: Novartis AG - Key news
Exhibits166: Novartis AG - Key offerings
Exhibits167: Novartis AG - Segment focus
Exhibits168: Pfizer Inc. - Overview
Exhibits169: Pfizer Inc. - Product / Service
Exhibits170: Pfizer Inc. - Key news
Exhibits171: Pfizer Inc. - Key offerings
Exhibits172: Sanofi SA - Overview
Exhibits173: Sanofi SA - Business segments
Exhibits174: Sanofi SA - Key news
Exhibits175: Sanofi SA - Key offerings
Exhibits176: Sanofi SA - Segment focus
Exhibits177: Viatris Inc. - Overview
Exhibits178: Viatris Inc. - Business segments
Exhibits179: Viatris Inc. - Key news
Exhibits180: Viatris Inc. - Key offerings
Exhibits181: Viatris Inc. - Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings